Format

Send to

Choose Destination

See 1 citation found by title matching your search:

  • Showing results for human[Title] AND vitro[Title] AND skin[Title] AND models[Title] AND ethical[Title] AND risk[Title] AND assessment[Title] AND metabolic[Title] AND considerations[Title]. Your search for Use of human in vitro skin models for a ccurate and ethical risk assessment: metabolic considerations retrieved no results.
Toxicol Sci. 2013 Jun;133(2):209-17. doi: 10.1093/toxsci/kft080. Epub 2013 Mar 28.

Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.

Author information

1
SWS, 64390 Erzhausen, Germany. nickyhewittltd@yahoo.co.uk

Abstract

Several human skin models employing primary cells and immortalized cell lines used as monocultures or combined to produce reconstituted 3D skin constructs have been developed. Furthermore, these models have been included in European genotoxicity and sensitization/irritation assay validation projects. In order to help interpret data, Cosmetics Europe (formerly COLIPA) facilitated research projects that measured a variety of defined phase I and II enzyme activities and created a complete proteomic profile of xenobiotic metabolizing enzymes (XMEs) in native human skin and compared them with data obtained from a number of in vitro models of human skin. Here, we have summarized our findings on the current knowledge of the metabolic capacity of native human skin and in vitro models and made an overall assessment of the metabolic capacity from gene expression, proteomic expression, and substrate metabolism data. The known low expression and function of phase I enzymes in native whole skin were reflected in the in vitro models. Some XMEs in whole skin were not detected in in vitro models and vice versa, and some major hepatic XMEs such as cytochrome P450-monooxygenases were absent or measured only at very low levels in the skin. Conversely, despite varying mRNA and protein levels of phase II enzymes, functional activity of glutathione S-transferases, N-acetyltransferase 1, and UDP-glucuronosyltransferases were all readily measurable in whole skin and in vitro skin models at activity levels similar to those measured in the liver. These projects have enabled a better understanding of the contribution of XMEs to toxicity endpoints.

KEYWORDS:

Cosmetics Europe.; human 3D skin models; keratinocytes; phase I and II metabolism; proteomics

PMID:
23539547
DOI:
10.1093/toxsci/kft080
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center